
Almost every man who starts testosterone replacement therapy eventually asks the same question, usually somewhere around month six: what happens if I stop? Sometimes it comes up because life changed — a move, a new job, a plan to start a family. Sometimes it's simple curiosity about whether the body ever goes back to running on its own. And sometimes it's the quiet worry that TRT is a one-way door.
It is a fair question, and it deserves a better answer than the two you usually find online: "you'll crash forever" or "just stop, you'll be fine." Neither is accurate. What the research actually shows is more nuanced, more reassuring in some ways, and slower in others than most men expect.
Here is what the evidence says about coming off testosterone therapy — how the body responds, how long recovery typically takes, what it means for fertility, and why the way you stop matters as much as whether you stop.
Testosterone production is governed by a feedback loop between the brain and the testes, usually called the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus and pituitary release signaling hormones — luteinizing hormone (LH) and follicle-stimulating hormone (FSH) — that tell the testes to make testosterone and sperm.
That loop is designed to self-regulate. When the brain detects plenty of circulating testosterone, it dials back LH and FSH. Exogenous testosterone — the kind delivered by injection, gel, or pellet — looks identical to the brain's sensors. So the signal goes down, and in many men on therapy, LH and FSH fall to very low or undetectable levels. In the HAARLEM study, a prospective cohort that followed men using androgens, suppression of the axis was essentially complete regardless of dose or duration.
This is not damage. It is the loop doing exactly what it is built to do. But it means that when the external testosterone goes away, the body does not simply flip back on. The signaling pathway has to wake up, and the testes have to respond to it again. That takes time.
This is the single most useful thing to understand before you make a decision: stopping TRT is not like stopping a blood pressure pill. There is a transition period, and planning for it changes the experience considerably.
The immediate timeline depends heavily on which formulation you were using, because each clears the body at a different rate.
As levels fall and before endogenous production resumes, most men pass through a window where testosterone is lower than it was either on therapy or before they started. This is the stretch people are describing when they talk about feeling flat after stopping. Fatigue, low mood, reduced libido, poorer sleep, and a general sense of being off are the commonly reported experiences.
FDA-approved prescribing information for testosterone products addresses this directly, and the distinction it draws is worth quoting carefully. The labeling notes that individuals taking supratherapeutic doses — meaning doses well above what is prescribed medically — may experience withdrawal symptoms lasting weeks or months, including depressed mood, major depression, fatigue, craving, restlessness, irritability, insomnia, decreased libido, and hypogonadotropic hypogonadism. The same labeling also states plainly that drug dependence in individuals using approved doses of testosterone for approved indications has not been documented.
In other words: the severe withdrawal picture that dominates online forums comes largely from the world of high-dose anabolic steroid use, not from monitored therapeutic dosing. That distinction matters, and it is one of the reasons supervised care and honest dosing are worth insisting on.
This is where the good data is genuinely helpful, because it is more specific than the guesswork that usually fills the gap.
The clearest evidence in men on therapeutic doses comes from a follow-up to the T4DM trial, sometimes called the Runoff study. It tracked men who had received two years of 1000 mg injectable testosterone undecanoate and then stopped. Researchers found that recovery of the reproductive hormone axis was eventually complete — but slow and progressive. The median time for serum LH to return to each man's own pre-treatment baseline was about 51 weeks, and for FSH about 53 weeks. Full recovery unfolded over roughly fifteen months from the last injection.
That is a year or more for the signaling hormones to fully normalize after two years of long-acting therapy. Importantly, the men in that study did not have pathological hypogonadism to begin with — their axes were capable of recovering.
Data from androgen users tells a somewhat different story on a different timescale. In the HAARLEM cohort, most men who had normal baseline gonadal function recovered normal testosterone levels within about three months of stopping, while LH recovery averaged closer to eleven months. Total testosterone, in other words, often normalizes before the upstream signaling does.
Pulling those threads together, a realistic framing looks something like this:
Several factors consistently predict a smoother recovery: younger age, shorter duration of therapy, preserved testicular volume, lower doses, and normal reproductive function before treatment began. Longer exposure and higher doses are associated with longer recovery — and in men who had genuine primary or secondary hypogonadism before starting, the axis may return only to its original impaired state, because the underlying condition never went anywhere.
That last point is the one most often missed. If low testosterone was the reason you started therapy, stopping does not cure it. It returns you to it.
For men in their thirties and forties, this is frequently the real motivation behind the question — and it deserves its own section.
Because FSH and intratesticular testosterone drive sperm production, suppressing the axis suppresses spermatogenesis. Sperm counts commonly fall substantially on testosterone therapy, and in some men reach zero. This is a well-documented effect, not a rare complication, and it is a genuinely important conversation to have before starting TRT rather than after.
The encouraging part: the published literature shows that the large majority of men recover sperm production after stopping. The sobering part is the timeline. Case series describe recovery commonly occurring within four to twelve months, with some men requiring twenty-four to thirty months to return to sperm concentrations above 20 million per milliliter. Longer and higher-dose exposure lengthens that window. Recovery is likely, but it is not guaranteed and it is not fast.
Urology guidance is consistent on the practical implication: men who are symptomatic from low testosterone and who want to preserve fertility are generally better served by treatments that stimulate their own production rather than by testosterone itself. Medications such as human chorionic gonadotropin (hCG) and selective estrogen receptor modulators like clomiphene are used for this purpose, and can also be used to support the axis when a man is coming off therapy. These uses are off-label in men — enclomiphene, for example, has not received FDA approval — and they require a prescriber who monitors closely. They are not something to source or self-administer outside of clinical care.
If fertility is anywhere in your five-year plan, raise it at your first consultation, not your fiftieth week of treatment. A baseline semen analysis before starting therapy is inexpensive information that becomes very valuable later.
Testosterone affects more than energy and libido, so discontinuation shows up in several places at once.
Testosterone therapy raises hemoglobin and hematocrit, and in some men causes erythrocytosis. Endocrine Society clinical practice guidance recommends checking hematocrit at baseline, again at three to six months, and annually thereafter — and if hematocrit exceeds 54%, stopping therapy until it returns to a safe level, evaluating for causes such as hypoxia and sleep apnea, and restarting at a reduced dose if appropriate. When therapy stops, this effect reverses as red blood cells turn over, which is one of the few unambiguous upsides of discontinuation for men who were running high.
Gains in lean mass supported by therapy are not automatically permanent. Without the hormonal support, maintaining that muscle depends more heavily on training stimulus and adequate protein intake. This is exactly the scenario where objective measurement beats the bathroom scale — body composition analysis distinguishes lean mass changes from fat and fluid shifts, so you can see whether you are actually losing muscle or simply losing water and reading it as failure.
These often dip during the transition window and improve as the axis recovers. They are also strongly influenced by variables that have nothing to do with testosterone — sleep quality, training load, stress, alcohol, and thyroid function among them. If symptoms persist well past the expected recovery window, that is a signal to investigate rather than to assume. Our guide on telling thyroid problems from hormonal ones covers the differential worth working through.
Blood pressure deserves a mention here. In February 2025, the FDA implemented class-wide labeling changes for testosterone products following review of the TRAVERSE trial and required postmarket ambulatory blood pressure monitoring studies. Those changes added TRAVERSE results to all testosterone labels, removed boxed warning language regarding increased risk of adverse cardiovascular outcomes, retained the "Limitation of Use" language for age-related hypogonadism, and added warnings about increased blood pressure. If your blood pressure rose on therapy, it is worth re-checking after stopping rather than assuming the reading is fixed.
There is no FDA-approved protocol for discontinuing testosterone therapy, and anyone who presents one as settled science is overselling. What follows is a description of how this decision is generally approached in supervised care — not a plan to follow on your own.
One more thing worth saying plainly: do not stop abruptly and alone, particularly if you have been on therapy for years or at high doses. Not because something catastrophic will happen, but because the months that follow are far easier to navigate with labs, a plan, and someone to interpret them.
Not necessarily. The axis is capable of recovering in men who had normal function before treatment. But if you started TRT because of diagnosed hypogonadism, stopping returns you to that baseline rather than resolving it. Whether therapy is long-term is a clinical question specific to your diagnosis, not a universal rule.
Most men feel worst in the first several weeks and improve over the following months. Published data on therapeutic dosing shows the hormone axis normalizing over roughly a year, though many men report feeling reasonably normal well before their labs fully recover.
Testicular volume commonly decreases during therapy and generally increases again as the axis recovers, though recovery of size can lag behind hormone levels and is not always complete.
"PCT" is a bodybuilding term, not a clinical protocol, and the evidence supporting standardized regimens is weak. Medications used to stimulate the axis do have real mechanisms and real clinical uses — but under supervision, with labs, and with an understanding that they are off-label in men.
Nothing in a wellness lounge restarts your HPG axis, and we would not suggest otherwise. What tools like infrared sauna, cold plunge, and contrast therapy can reasonably support is sleep quality, training recovery, and stress — the same inputs that influence how you feel during a hormonal transition. That is a supporting role, not a substitute for clinical care.
Muscle preservation becomes more important when both hormonal support and caloric intake are reduced at the same time. Our guide on protecting lean mass during GLP-1 weight loss covers the training and protein strategy, and it applies with more urgency during a TRT transition.
Stopping testosterone therapy is a reversible decision for most men who had a functional axis to begin with — but it is a slow reversal, measured in months rather than weeks, and the tail end is longer than almost anyone expects. Fertility usually recovers, though it can take a year or more. Symptoms typically dip before they improve. And if low testosterone was a real diagnosis rather than an optimization goal, stopping brings that diagnosis back.
None of that argues for or against discontinuation. It argues for doing it deliberately: with labs, with a timeline, and with a provider who will tell you what the numbers mean rather than what you hoped they would say.
If you want the fuller picture before deciding, our guides on what current testosterone guidelines mean for you and how long TRT takes to work cover the other side of the same timeline.
If you are on testosterone therapy and wondering whether to continue, taper, or stop — or if you are considering starting and want to understand the commitment first — that conversation belongs in a consultation, not a comment section.
At Contour Medical Clinic in Tarzana, hormone care is built around diagnostic testing and follow-up rather than a single prescription. We serve patients across Tarzana, Encino, Woodland Hills, Sherman Oaks, and the wider San Fernando Valley. Learn more about our approach to TRT and hormone optimization, or schedule a TRT consultation to review your labs, your goals, and your options with a clinician.
Book your consultation and get an answer built on your bloodwork instead of someone else's forum post.
This article is for general educational purposes and is not medical advice. Do not start, change, or stop testosterone therapy without consulting a qualified healthcare provider who knows your medical history.
Written by: Contour Medical Clinic Editorial Team